Iyuzeh first preservative‑free latanoprost

- Ophthalmology Times reviewed Iyuzeh and highlights it as the first preservative-free latanoprost formulation, set against traditional BAK-preserved options. (ophthalmologytimes.com) - The article notes Iyuzeh received FDA approval in December 2022 and uses that product as the explicit comparator to BAK‑preserved latanoprost drops. (ophthalmologytimes.com) - The comparison frames preservative-free latanoprost as a tolerability option for patients with ocular-surface disease who cannot tolerate BAK, according to the piece. (ophthalmologytimes.com)